Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details Narrative)

v3.20.1
NON CONTROLLING INTEREST (Details Narrative) - BioCorRx Pharmaceuticals, Inc [Member] - USD ($)
Mar. 31, 2020
Jul. 28, 2016
Ownership percentage hold by former officers   24.20%
Ownership percentage hold by company   75.80%
Licensing rights, carrying value $ 250,000